1. Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study
   Su Jong Yu et al, 2017, J. Proteome Res. CrossRef
2. Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
   Benedek Gyöngyösi et al, 2014, J Histochem Cytochem. CrossRef
3. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma
   Haruhiko Takeda et al, 2014, Hepatol Res CrossRef
4. A retrospective study of initial dose of sorafenib therapy in Japanese patients with unresectable hepatocellular carcinoma -experiences from a single center
   Haruhiko Takeda et al, 2013, Kanzo CrossRef
5. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma
   Hiroki Nishikawa et al, 2014, Hepatol Res CrossRef
6. Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization
   Martha M. Kirstein et al, 2017, Scandinavian Journal of Gastroenterology CrossRef
7. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)
   Hyunsoo Kim et al, 2017, Mol Cell Proteomics CrossRef
8. High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma
   Shintaro Takaki et al, 2019, mol clin onc CrossRef
9. Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer
   Matthias Philipp Fabritius et al, 2021, JCM CrossRef
10. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS
    Lena Stockhoff et al, 2021, Hepatol Commun CrossRef
11. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
    Hailiang Ran et al, 2022, BMC Cancer CrossRef
12. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
    Shan Lu et al, 2022, BMC Complement Med Ther CrossRef
13. Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
    Yikai Wang et al, 2023, Sci Rep CrossRef
14. Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer
    Kimihiko Nakamura et al, 2024, Annals of Gastroent Surgery CrossRef
15. Personalized venlafaxine dose prediction using artificial intelligence technology: a retrospective analysis based on real-world data
    Yimeng Liu et al, 2024, Int J Clin Pharm CrossRef
16. Synthesis and Structure of Novel Phenothiazine Derivatives, and Compound Prioritization via In Silico Target Search and Screening for Cytotoxic and Cholinesterase Modulatory Activities in Liver Cancer Cells and In Vivo in Zebrafish
    Mehmet Murat Kisla et al, 2024, ACS Omega CrossRef